{"SPADE_UN_16295": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16295", "Peptide Name": "AmphiArc2 Off2.1", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "QVFKKFRPFYRRPWELFGKL", "Sequence Length": 20, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MCF-7 (EC50=91 ± 2 µM); A549 (EC50>100 µM)", "Hemolytic Activity": "Human erythrocytes:HC50>200 µM", "Cytotoxicity": "HDMEC:EC50=173 ± 1 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C131H192N34O25", "Mass": 2643.14, "PI": 11.07, "Net Charge": 5, "Hydrophobicity": -0.75, "Half Life": "Mammalian:0.8 hourYeast:10 minE.coli:>10 hour", "Literature": [{"Title": "In silico design and optimization of selective membranolytic anticancer peptides", "Pubmed ID": "31375699", "Reference": "Sci Rep. 2019 Aug 2;9(1)11282.", "Author": "Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31375699"}], "Frequent Amino Acids": "FKR", "Absent Amino Acids": "ACDHIMNOSTU", "Basic Residues": 6, "Acidic Residues": 1, "Hydrophobic Residues": 11, "Polar Residues": 9, "Positive Residues": 6, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06995", "Similarity": 0.8571428571428571, "Sequence": "FKKFRKF"}, {"SPADE_ID": "SPADE_N_02801", "Similarity": 0.8333333333333334, "Sequence": "GLFGKLIKKFGRKAISYAVKKARGKH"}, {"SPADE_ID": "SPADE_N_02802", "Similarity": 0.8333333333333334, "Sequence": "GLFGKLIKKFGRKAISYAVKKARGKN"}]}}}